Use of bortezomib in the treatment of refractory autoimmune hemolytic anemia in a patient with systemic lupus erythematosus. Acervo Saúde [Internet]. 2025 Aug. 5 [cited 2026 Nov. 3];25(8):e20869. Available from: https://acervomais.com.br/saude/article/view/20869